Anuj Hasija
CIK: 0002058570
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABUS
Arbutus Biopharma Corp
Director
Discretionary Trading P&L
Holdings
About Hasija Anuj
Hasija Anuj (SEC CIK 0002058570) files insider reports with the SEC as Director of Arbutus Biopharma Corp (ABUS).
Signal8 holds 2 ownership filings by Hasija Anuj (1 Form 3, 1 Form 4), filed between Mar 6, 2025 and Mar 20, 2025. Those filings report 1 transaction, the latest on Mar 18, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Hasija Anuj's filings is in WARMINSTER, PA.
Recent filings by Hasija Anuj
- Mar 18, 2025: Grant or award of ABUS derivative securities (Form 4, code A).
Other insiders filing for Arbutus Biopharma Corp (ABUS)
- Beardsley Robert A, Director
- Nguyen Tuan, Chief Financial Officer
- Sawhney Roger, Director
- Androski Lindsay, President and CEO
- Bishop Joseph E, Director
- Gline Matthew, Director